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A B S T R A C T
A novel L-glutamate-gated anion channel (IscaGluCl1) has been cloned from the black-legged tick, Ixodes sca-
pularis, which transmits multiple pathogens including the agents of Lyme disease and human granulocytic
anaplasmosis. When mRNA encoding IscaGluCl1 was expressed in Xenopus laevis oocytes, we detected robust
50–400 nA currents in response to 100 μM L-glutamate. Responses to L-glutamate were concentration-dependent
(pEC50 3.64 ± 0.11). Ibotenate was a partial agonist on IscaGluCl1. We detected no response to 100 μM as-
partate, quisqualate, kainate, AMPA or NMDA. Ivermectin at 1 μM activated IscaGluCl1, whereas picrotoxinin
(pIC50 6.20 ± 0.04) and the phenylpyrazole ﬁpronil (pIC50 6.90 ± 0.04) showed concentration-dependent
block of the L-glutamate response. The indole alkaloid okaramine B, isolated from fermentation products of
Penicillium simplicissimum (strain AK40) grown on okara pulp, activated IscaGluCl1 in a concentration-dependent
manner (pEC50 5.43 ± 0.43) and may serve as a candidate lead compound for the development of new acar-
icides.
1. Introduction
Ticks are major ectoparasites of livestock and are also vectors of
human and animal diseases worldwide (Jongejan and Uilenberg, 2004).
They transmit a greater diversity of infectious agents than any other
group of blood-feeding arthropods (Gulia-Nuss et al., 2016), including
the Lyme disease spirochaete, Borrelia burgdorferi (Burgdorfer, 1984),
and many other human and animal pathogens. At present, only a lim-
ited number of chemicals are available for their control (Woods and
Williams, 2007; Van Leeuwen et al., 2015). Improved understanding of
the molecular targets of tick control chemicals (acaricides) will enhance
our ability to tackle tick-borne livestock diseases, with important im-
plications for veterinary medicine. L-glutamate-gated chloride channels
(GluCls), which belong to the di-cysteine loop-containing superfamily
of ligand-gated ion channels (Cys-loop LGICs), are present in in-
vertebrates but not vertebrates and are therefore suitable targets for
antiparasitic drugs, most of which show good host-tolerance (Raymond-
Delpech et al., 2005; Wolstenholme, 2012). For example, GluCls are
activated by the endectocide ivermectin (22, 23-dihydro-avermectin
B1a), a macrocyclic lactone isolated from the actinomycete, Strepto-
myces avermitilis, which controls both nematode endoparasites and ec-
toparasites such as ticks (Rugg et al., 2005). Ivermectin also targets
GABA-gated chloride channels (Duce and Scott, 1985; Sattelle, 1990).
First introduced in 1981, by the second half of that decade ivermectin
had become the world's biggest-selling animal health product (Omura
and Crump, 2014).
Other chemotypes targeting arthropod Cys-loop LGICs include the
phenylpyrazole, ﬁpronil (Cole et al., 1993; Davey et al., 1998; Denny,
2001; Zheng et al., 2003; Raymond-Delpech et al., 2005), and the iso-
xazolines, a group including ﬂuralaner, afoxalaner and sarolaner (Ozoe
et al., 2010; García-Reynaga et al., 2013; Gassel et al., 2014; Shoop
et al., 2014; McTier et al., 2016), which block GABA-gated chloride
channels and GluCls. Fluralaner is eﬀective against multiple life stages
of ticks of the Ixodidae and Argasidae families (Gassel et al., 2014;
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Rohdich et al., 2014; Wengenmayer et al., 2014; Williams et al., 2015).
Okaramines are indole alkaloids isolated from fermentation products of
Penicillium simplicissimum (strain AK40) grown on the okara pulp re-
sulting from Soybean cake production. They are toxic to larvae of the
silkworm, Bombyx mori (Bm) (Hayashi et al., 1989) and show strong
selectivity for these lepidopteran BmGluCls (Furutani et al., 2014b). For
example, they activate BmGluCls but not the silkworm GABA receptor
(BmRDL). They are also ineﬀective on both human GABA-gated
chloride channels (type A GABA receptors) and glycine-gated chloride
channels (GlyCls) (Furutani et al., 2014b). Furthermore, their in-
secticidal proﬁle agrees well with their LD50 proﬁle on lepidopteran
larvae (Furutani et al., 2017). To our knowledge, okaramine B has not
been tested on tick GluCls.
Many invertebrate genomes have now been sequenced providing
access to GluCls from many pests and parasites (Wolstenholme, 2012).
Completion of the genomes of the medically important tick, Ixodes
scapularis (Gulia-Nuss et al., 2016), and the agricultural pest, the two-
spotted spider mite, Tetranychus urticae (Grbić et al., 2011), indicates
that the acarine GluCl family may be quite diverse. We recently cloned
and heterologously expressed in Xenopus laevis oocytes a member of this
family from I. scapularis (IscaGluCl1) which formed a presumed
homomeric functional GluCl responding to L-glutamate but none of the
other neurotransmitters (GABA, 5-HT, ACh, dopamine, tyramine and
histamine) known to activate particular invertebrate ligand-gated anion
channels (Gulia-Nuss et al., 2016). This expressed GluCl was also un-
responsive to glycine, which together with GABA (Olsen et al., 1999) is
an important inhibitory neurotransmitter in mammalian brain.
Here we describe aspects of the pharmacology of IscaGluCl1, in-
cluding the actions of ibotenate, picrotoxinin, ﬁpronil, ivermectin and
the novel indole-alkaloid, okaramine B, which activates the receptor.
Okaramine B may therefore serve as a candidate lead not only for the
development of novel insecticides (Furutani et al., 2014b, 2017), but
also for the development of novel acaricides.
2. Materials and methods
2.1. Cloning of an Ixodes scapularis GluCl, IscaGluCl1
Unfed adult male and female Ixodes scapularis ticks (Wikel strain)
(stored in RNAlater®) were kindly supplied by Professor Daniel
Sonenshine. A mixed population of adults (ranging from 2 to 3 unfed
adult ticks — mixed sex for each extraction) were stored in TRIzol® and
homogenised using a Vibration Mixer Mill Retsch MM300, and total
RNA was extracted according to the manufacturer's protocol. Tick (I.
scapularis) cDNA was prepared using oligo dT(15) (Promega) and
MMLV-RT RNaseH- (Promega). A partial predicted I. scapularis GluCl
gene was identiﬁed from Vectorbase (ISCW022629). The full-length
gene was obtained using degenerate primers based on the previously
identiﬁed RsGluCl1 sequence (ACX33155 and US patent 7202054). The
full length sequence was deposited in NCBI under accession number
KR107244. The complete coding sequence of IscaGluCl1 was cloned
into the p-GEM-T-Easy vector (Promega), and transcribed using SP6
Message Machine kit (Ambion) after linearisation with ApaI prior to
oocyte injection.
2.2. Chemicals
L-Glutamate, D-glutamate, ivermectin and picrotoxinin (PTX) were
obtained from Sigma-Aldrich (UK). Fipronil was a gift from Dr. Lance
Hammerland (Merial Ltd). Kainic acid (referred to as kainate
throughout this paper), N-methyl-D-aspartic acid (NMDA), quisqualic
acid (referred to as quisqualate throughout this paper), L-aspartatic acid
(referred to as aspartate throughout this paper), α-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid (AMPA) were obtained from Tocris
(UK), whereas ibotenic acid (referred to as ibotenate throughout this
paper) was obtained from Wako Pure Chemical Industries (Osaka,
Japan). Okaramine B was isolated from fermentation products of P.
simplicissimum according to the original paper (Hayashi et al., 1989).
2.3. Electrophysiology on IscaGluCl1 expressed in Xenopus laevis oocytes
Ovaries were removed from adult female Xenopus laevis under an-
aesthetic (1.5 g L tricaine) according to the UK Animals (Scientiﬁc
Procedures) Act 1986. Isolated oocytes were defolliculated manually
following a 30min incubation with collagenase type 1 A (2mg ml)
(Sigma) and each oocyte was injected with 50 ng of cRNA encoding
IscaGluCl1. Oocytes prepared in this way were maintained in standard
oocyte saline (SOS) at 16 °C (Buckingham et al., 2006). Membrane
currents were recorded 24–48 h post-injection using standard two-
electrode voltage clamp methods, with oocytes voltage-clamped at Eh
−80mV (Buckingham et al., 2006) unless otherwise stated. Data were
only collected from oocytes which yielded stable responses to at least
three control doses of 100 μM L-glutamate applied at 3min intervals.
Agonist actions of test compounds were examined by challenging
the oocyte with increasing concentrations of agonist for 5 s at a ﬂow-
rate of 7–10mlmin with at least 3 min between challenges to minimise
the eﬀects of desensitisation. Peak amplitudes of responses were nor-
malised to the response to 1mM L-glutamate. To evaluate allosteric or
antagonist actions, test compounds were ﬁrst applied alone for 1min
and then co-applied with agonists. In this case, peak amplitudes of
observed responses were normalised to the response to 100 μM L-glu-
tamate. For studies on the blocking actions of picrotoxinin and ﬁpronil,
only a single concentration of compound was tested on an individual
oocyte. Picrotoxinin, ivermectin, ﬁpronil and okaramine B were ﬁrst
dissolved in dimethylsulphoxide (DMSO) and then diluted in SOS to the
required concentrations. Care was taken that the ﬁnal concentration of
DMSO did not exceed 1% (v/v) to prevent any impact of DMSO on
electrophysiological recordings.
2.4. Data analysis
Data are presented as mean ± SEM of 2–6 independent experi-
ments. Data were normalised to the peak amplitude evoked by either
1mM or 100 μM L-glutamate as indicated in the previous section and
analysed using GraphPad Prism version 5.0 (GraphPad Software Inc.,
USA). To calculate concentration-response relationships, normalised
data were ﬁtted to the following equation:
= +
−
+
−
Y I I I
1 10min
max min
EC X n( log ) H50 (1)
where Y is the normalised response amplitude, Imax and Imin are the
maximum and minimum normalised responses respectively, EC50 is the
concentration giving half the maximum normalised response, X is log
[Agonist/Antagonist (M)] and nH is the Hill coeﬃcient. To obtain the
concentration-inhibition relationship, the response after co-application
of agonist and antagonist was normalised to the control response to
100 μM L-glutamate and analysed to obtain the pIC50 value, using
above equation but in this case the pEC50 was replaced with pIC50 and
Imax was constrained to be 1. Statistical tests were performed for com-
parison of pIC50 values using t-test with a signiﬁcance level of
P < 0.05.
3. Results
3.1. Sequence of IscaGluCl1
The full-length IscaGluCl1 DNA (1350 nucleotides) encodes a 449
amino acid protein which shows the characteristic features of a Cys-
loop LGIC subunit including: a large extracellular N-terminal domain, a
dicysteine loop (Cys-loop) with cysteines separated by 13 residues, 4
transmembrane (TM) regions and a large intracellular TM3-TM4 loop
(Fig. 1). A second N-terminal loop, characteristic of ligand-gated anion
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channels (Wolstenholme, 2012), is also present. A PAR motif at the
inner end of the second transmembrane segment (TM2) is typical of
Cys-loop ligand-gated anion channels (Raymond and Sattelle, 2002)
(Fig. 1). BLASTp analysis using the NCBInr database showed this se-
quence to be most similar to arthropod GluCls with highest hits to: the
cattle tick, Rhipicephalus microplus (AHE41097), with 94% identity
(E=0.0), the common house spider, Parasteatode tepidariorum
(XP_015920421), with 84% identity (E=0.0), the Atlantic horseshoe
crab, Limulus polyphemus (XP_013782904), with 78% identity (E=0.0)
and the brown marmorated stink bug, Halyomorpha halys
(XP_014282882), with 73% identity (E=0.0). Phylogenetic analysis
with known (or predicted) insect, arachnid or helminth GluCls shows
that this receptor clusters closely with the arachnid GluCls, including
the previously characterised R. microplus and R. sanguineus GluCls.
Fig. 1. Multiple sequence alignment of the Ixodes scapularis GluCl (IscaGluCl1) with GluCls from other arthropods and C. elegans. This multiple sequence
alignment indicates that IscaGluCl1 shares characteristic sequence features with known GluCls. Multiple sequence alignments were performed with the MAFFT
(Yamada et al., 2016) algorithm using Geneious software versiton 9 (Kearse et al., 2012), and the details were adjusted manually - gaps originally produced by
MAFFT at N-/C-terminal were removed, and alignment between TM3 and TM4, a poorly conserved region, were corrected in order to reduce gaps. Accession numbers
of the GluCls depicted from C. elegans, D. melanogaster, I. scapularis and T. castaneum are AAA50785, AAG40735, ALF36853 and NP_001107775, respectively.
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Therefore, this receptor was designated IscaGluCl1 (Fig. 2).
3.2. Actions of L-glutamate, ibotenate, kainate, quisqualate, NMDA, AMPA
and aspartate on functionally-expressed, recombinant IscaGluCl1
Bath-application of L-glutamate resulted in a rapid onset, con-
centration-dependent, inward current in Xenopus laevis oocytes in-
jected with IscaGluCl1 cRNA and clamped at Eh −80 mV (Fig. 3A).
Such currents were not seen in control oocytes injected with distilled
water. The response to L-glutamate reversed at a membrane potential
of −27.5 ± 1.1 mV (n= 4) in SOS where the extracellular Cl−
concentration is 107.6 mM. The reversal potential is close to the
chloride equilibrium potential (ECl) of −28 mV for X. laevis oocytes
(Costa et al., 1989). By comparison, the reversal potential for po-
tassium currents has been reported to be−84 mV (Peres et al., 1985),
whilst the reversal potentials for sodium and calcium are expected to
be positive. In addition, the reversal potential shifted to
+4.1 ± 1.9 mV (n = 4), which is close to a predicted value of
+1.6 mV, when the extracellular Cl− concentration was changed to
37.6 mM (Fig. 3B). A pEC50 value of 3.64 ± 0.11 (EC50 230 μM) was
estimated for L-glutamate applied to IscaGluCl1 (Fig. 3C, Table 1).
Ibotenate, a known activator of IscaGluCl1 (Gulia-Nuss et al., 2016),
was a partial agonist with a higher aﬃnity (pEC50 4.97 ± 0.25; EC50
10.8 μM) for IscaGluCl1 than L-glutamate (Fig. 3C, Table 1). We
showed previously that agonists known to activate vertebrate and
invertebrate chloride channels including ACh, GABA, glycine, hista-
mine, tyramine, dopamine and 5-HT were inactive at 1 mM (Fig. 3D)
(Gulia-Nuss et al., 2016). These ﬁndings together with stereo-se-
lectivity (L-glutamate > D-glutamate) identiﬁed this LGIC subunit as
a GluCl (Gulia-Nuss et al., 2016). We therefore tested other L-gluta-
mate analogues, some of which in vertebrates help deﬁne L-glutamate
receptor subtypes. These were kainate, NMDA, quisqualate, AMPA
and L-aspartate. All were found to be inactive at 100 μM (data not
shown).
3.3. Picrotoxinin and ﬁpronil block IscaGluCl1
Picrotoxinin, a channel-acting blocker of many GluCls (Hibbs and
Gouaux, 2011), at 100 μM blocks the response of IscaGluCl1 to 100 μM
L-glutamate. This block was concentration-dependent with a pIC50 of
6.20 ± 0.04 (IC50 638 nM) (Fig. 4, Table 2). The phenylpyrazole, ﬁ-
pronil, is an important antiparasitic compound used widely for the
treatment of ﬂeas and ticks with actions at both arthropod GABARs
(Hosie et al., 1995) and GluCls (Furutani et al., 2014a; Kita et al.,
2014). A concentration-dependent block by ﬁpronil was observed with
a pIC50 of 6.90 ± 0.04 (IC50 125 nM) (Fig. 4, Table 2). For both an-
tagonists, their blocking actions were irreversible at most concentra-
tions and thus only one concentration was tested per oocyte in this
series of experiments. Thus IscaGluCl1 is targeted by both picrotoxinin
and ﬁpronil, both of which suppress in a concentration-dependent
manner the actions of L-glutamate.
3.4. Ivermectin and okaramine B activate IscaGluCl1
Ivermectin activated IscaGluCl1 (pEC50 5.71 ± 0.05) in a con-
centration-dependent manner (Fig. 5) resulting in the generation of
sustained inward currents recorded at Eh=−100mV. Okaramine B at
1 μM, 3 μM and 10 μM transiently activated IscaGluCl1 in a
Fig. 2. Phylogenetic analysis of known arthropod and helminth GluCls. This analysis indicates that IscaGluCl clusters closely with tick GluCl1 homologues,
hence the receptor has been labelled IscaGluCl1. The phylogenetic tree was constructed using Geneious software version 9 (Kearse et al., 2012) with genetic distance
model of Jukes-Cantor, and with Neighbour-Joining methods. Scale bar indicates substitutions per site.
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concentration-dependent manner (Fig. 5). The resulting inward current
transients recorded at Eh −100mV for both ivermectin and okaramine
B showed much slower rise times than those observed for L-glutamate.
Unlike the case for ivermectin, okaramine B responses reversed quickly
once the oocyte was re-bathed in saline. From the concentration-re-
sponse curve constructed from responses to okaramine B over the range
10 nM–30 μM, a value for the pEC50 of 5.43 ± 0.43 (EC50 3.70 μM) was
determined (Fig. 5).
Fig. 3. Concentration-dependent responses to L-glutamate and ibotenate of recombinant homomeric IscaGluCl1 expressed in Xenopus laevis oocytes and
the current-voltage relationship for the response to L-glutamate. A, rapidly activated and desensitized response to L-glutamate of IscaGluCl1 at three con-
centrations. B, peak current amplitude of the response to 1mM L-glutamate at two external Cl− concentrations. C, concentration-response relationship for L-
glutamate and ibotenate. Ibotenate is a partial agonist but shows higher aﬃnity for IscaGluCl1 than L-glutamate. Data were normalised to 1mM L-glutamate. pEC50s
are given in Table 1. In B and C, each data plot represents mean ± standard error of the mean (n= 4). D, percent maximal L-glutamate responses to neuro-
transmitters applied at 1mM of IscaGluCl1. Each bar graph represents mean ± standard error of the mean (n=3–6).
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3.5. Okaramine allosterically potentiates L-glutamate responses of
IscaGluCl1
Ivermectin is known to act as an allosteric modulator of glutamate-
gated chloride channels. and we postulated that okaramine B may also
act in a similar way. Hence, okaramine B was applied alone for 1min at
a low concentration (1 μM) followed by co-application with 100 μM L-
glutamate. This resulted in an enhanced amplitude of the response to L-
glutamate (Fig. 6A) when compared to controls, highlighting that
okaramine B acts as a potent, positive allosteric modulator on Isca-
GluCl1 (Table 3). Thus the action of okaramine B on IscaGluCl1 diﬀers
markedly from its previously reported actions on a lepidopteran GluCl
(BmGluCl of the silkworm larva Bombyx mori) (Furutani et al., 2014a,b,
2017), where only agonist actions have been described and its in-
secticidal action can be explained entirely in terms of its GluCl acti-
vation. The potency of okaramine B measured as pEC50 for the positive
allosteric modulation of IscaGluCl1 was 5.95 ± 0.03 (1.13 μM),
(Fig. 6B, Table 3). We also determined the eﬀects of 1 μM okaramine B
on the concentration-response curve for L-glutamate (Fig. 6C). Okar-
amine B (1 μM) had a minimal impact on the pEC50 value
(3.62 ± 0.12 with no alkaloid present compared to 3.88 ± 0.04 in the
presence of 1 μM okaramine B) (Table 3).
3.6. Ivermectin activation of IscaGluCl1 is blocked non-competitively by
okaramine B
Ivermectin activated IscaGluCl1 in a concentration-dependent
manner (1–100 μM). Okaramine B suppressed the amplitude of the
ivermectin response while scarcely inﬂuencing pEC50 indicating a non-
competitive type of action. The simplest explanation is that ivermectin
and okaramine B act at close, but distinct, sites on IscaGluCl1 (Fig. 7,
Table 4).
Table 1
Agonist activity of L-glutamate and ibotenate on the recombinant expressed L-
glutamate gated chloride channel (IscaGluCl1) of the tick, Ixodes scapularis.
Compound EC50 (μM) (95% Conﬁdence Interval) pEC50 Imax
L-Glutamate 230 (141–377) 3.64 ± 0.11 1.35 ± 0.07
Ibotenate 10.8 (3.36–34.7) 4.97 ± 0.25 0.50 ± 0.05
Data were normalised to the response to 1mM L-glutamate and are represented
as mean ± standard error of the mean (n= 4). The pEC50s for L-glutamate and
ibotenate were signiﬁcantly diﬀerent (two-tailed t-test, p < 0.05).
Fig. 4. Inhibition by picrotoxinin and ﬁpronil of recombinant homomeric IscaGluCl1 expressed in Xenopus laevis oocytes. A. Block by picrotoxinin and
ﬁpronil (100 nM) of L-glutamate responses (100 μM) recorded from IscaGluCl1 heterologously expressed in Xenopus laevis oocytes. B. Concentration-inhibition
relationships for the actions of picrotoxinin and ﬁpronil on responses to L-glutamate of IscaGluCl1. Data were normalised to the response to 100 μM L-glutamate.
Each data point is represented by the mean ± standard error of mean (n= 4). Curves are ﬁts to Eq. (1) and IC50s are given in Table 2.
Table 2
Antagonist activity of picrotoxinin and ﬁpronil on the recombinant expressed L-
glutamate-gated chloride channel (IscaGluCl1) of the tick, Ixodes scapularis.
Compound IC50 (μM) (95% Conﬁdence Interval) pIC50
Picrotoxinin 0.64 (0.52–0.78) 6.20 ± 0.04
Fipronil 0.13 (0.10–0.15) 6.90 ± 0.04
Data were normalised to the amplitude of the response to 100 μM L-glutamate
and are represented as mean ± standard error of the mean of 4 experiments.
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4. Discussion
There is evidence, albeit incomplete, that L-glutamate is a neuro-
transmitter in ticks (Booth et al., 1985; Lucien et al., 1995). For ex-
ample, orthologues of L-glutamate-gated chloride channels (GluCls) are
present in all species of ticks studied to date. Here we describe the full
length sequence of a tick GluCl from the Lyme disease vector, I. sca-
pularis. IscaGluCl1 was designated a GluCl because only L-glutamate, of
all the invertebrate neurotransmitters known to gate anion channels,
was active (Gulia-Nuss et al., 2016). In addition, its pharmacological
proﬁle resembles that of an L-glutamate-gated chloride channel from
the genetic model organism, D. melanogaster (DrosGluCl-α), where L-
glutamate activates the receptor and ibotenate is a partial agonist (Cully
et al., 1996). Detailed concentration-response studies presented here
show that ibotenate is a partial agonist of IscaGluCl1 but, unlike the
case for DrosGluClα, ibotenate has a slightly higher aﬃnity for the
receptor than L-glutamate. We have already shown that L-glutamate is
more potent than D-glutamate on IscaGluCl1 conﬁrming the anticipated
stereo-selectivity for L-glutamate (Gulia-Nuss et al., 2016).
IscaGluCl1 and other putative GluCls identiﬁed from R. sanguineus
show low homology to insect GluCls but relatively poor sequence
identity is not unusual for comparisons between insect and arachnid
GluCl homologues (Lees et al., 2010). Prior to the advancement of
genome sequencing technologies, Cully et al. (1996) were unsuccessful
in isolating GluCl transcripts from the spider mite T. urticae using D.
melanogaster GluCl primers. Indeed, the recent study of the Cys-loop
LGIC family from T. urticae has shown that all 6 identiﬁed T. urticae
GluCls are phylogenetically divergent from insect GluCls (Dermauw
et al., 2012), which could explain the cloning diﬃculties encountered
in earlier studies. With the exception of RsGluCl1, RmGluCl and Isca-
GluCl1 (which most closely resemble DrosGluCl-α), most tick sequences
that have been identiﬁed as candidate GluCls from I. scapularis(Gulia-
Nuss et al., 2016), R. sanguineus and Dermacentor variabilis are phylo-
genetically distinct from GluCls of other arthropods (Lees and Bowman,
2007).
We have shown that IscaGluCl1 is blocked by picrotoxinin, as is the
case for many, though not all, invertebrate GluCls such as GLC-3 in C.
elegans (Horoszok et al., 2001; Wolstenholme, 2012). Another C. elegans
GluCl (CeGluClα) is sensitive to picrotoxinin (Cleland, 1996). The pIC50
for picrotoxinin's action on IscaGluCl (6.2 μM) was lower than that for
houseﬂy (Musca domestica) GluCl (3.97 μM, Eguchi et al., 2006). Hibbs
and Gouaux (2011) reported the structure of CeGluClα with picrotox-
inin bound showing that the fused tricyclic rings of picrotoxinin are
directed extracellularly and close to the threonine located at position 2'
(based on the notation introduced by Henry Lester (1992) for the
second transmembrane region (TM2) of Cys Loop LGICs). The isoprenyl
tail is directed toward the cytoplasm and is proximal to the proline
residues at position -2′ in TM2 of CeGluClα. In IscaGluCl1 a proline is
also present at -2′ and a serine, which like threonine is an amino acid
with polar but uncharged side chains, is present at position 2'. Thus key
components of the picrotoxinin binding site seen in CeGluClα are also
present in IscaGluCl1. However, residues other than those at the base of
TM2 must account for the diﬀerences in picrotoxinin sensitivity seen
between some other members of the GluCl family since the picrotox-
inin-insensitive subunit from C. elegans (GLC-3) (Horoszok et al., 2001)
also has proline at -2′ and threonine at position 2'. The residue in the 6′
position of the Varroa mite has also been shown to be important
(Carpenter et al., 2013). We also show, as is the case for RmGluCl (the
GluCl cloned from the cattle tick, Rhiphicepalus microplus) (Gassel et
2014), that ﬁpronil and ivermectin respectively block and activate Is-
caGluCl1.
The endectocide ivermectin (Omura, 2008; Crump et al., 2012;
Omura and Crump, 2014) is active on insect RDL GABA-gated chloride
channels (Zheng et al., 2003), insect muscle GABA-gated chloride
channels and insect muscle GluCls (Duce and Scott, 1985). Kaufman
et al. (1986) showed that intra-haemocoelic injection of ivermectin was
detrimental to salivary gland function in the female tick A. hebraeum. It
is likely that the observed eﬀects of ivermectin are indirect as the
salivary glands are highly innervated (Binnington and Obenchain,
1982; Lees et al., 2010). Ivermectin binds at the interface of M3 on the
principal subunit and M1 on the complementary subunit, with the
binding site centering on a region between residues leucine 217 and
isoleucine 222 on M1. In GluClα, Ser 260, which is also conserved in
IscaGluCl, forms a hydrogen bond with the secondary hydroxyl group
Fig. 5. Concentration-dependent activation of IscaGluCl1 by ivermectin (A) and okaramine B (B). Each data point represents the mean ± standard error of the
mean (n= 4, from 2 experiments). Data were normalised to the response to 1 mM L-glutamate. Curves are ﬁts to Eq. (1). Above the concentration-response curve,
individual responses of IscaGluCl1 (recorded with oocyte voltage-clamped at Eh=−100mV) to 1 μM, 3 μM and 10 μM ivermectin (A) or okaramine B (B) are shown.
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on the cyclohexene ring of ivermectin. As noted by Hibbs and Gouaux, a
serine at the equivalent position is also present in human GlyRs and
both receptors are directly activated by ivermectin (Hibbs and Gouaux,
2011).
Ivermectin, picrotoxinin and ﬁpronil also target the D. melanogaster
GluCl (DrosGluCl-α) (Cully et al., 1996) and histamine-gated chloride
channel (Iovchev et al., 2002; Yusein et al., 2008), as well as pH-sen-
sitive chloride channels in silkworm larvae (Nakatani et al., 2016) and
the glycine receptor in humans (Shan et al., 2001). Thus in insects,
ivermectin can target multiple types of ligand-gated anion channels.
Fipronil is a potent blocker of both GABA receptors (Zhao et al., 2003)
and GluCls (Ikeda et al., 2001; Zhao et al., 2004; Eguchi et al., 2006;
Fig. 6. Positive allosteric modulation by Okaramine B of responses to L-glutamate mediated by IscaGluCl1. A) Responses IscGluCl1 to 100 μM L-glutamate are
enhanced by preincubation in 1 μM okaramine-B. B) The enhancement by okaramine-B of responses to 100 μM L-glutamate is concentration-dependent. C)
Concentration-response curves for L-glutamate in the presence and absence of 1 μM okaramine-B.
Table 3
Allosteric modulation by okaramine B of the response to L-glutamate of
IscaGluCl1.
Compound EC50 (μM) (95%
Conﬁdence Interval)
pEC50 Imax
L-Glutamate 242 (139–421) 3.62 ± 0.12 1.40 ± 0.07
L-Glutamate +
1 μM okaramine B
132 (108–161) 3.88 ± 0.04 2.66 ± 0.05
Data were normalised to the response to 1mM L-glutamate and are represented
as mean ± standard error of the mean (n=4).
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Narahashi et al., 2007). In the case of ﬂuralaner, comparative studies
have shown that R. microplus RDL is 52-fold more sensitive than R.
microplus GluCl (Gassel et al., 2014), indicating that the GABA-gated
chloride channel is the primary target of this isoxazoline parasiticide.
Other isoxazolines are also potent inhibitors of GABA-gated chloride
channels. For example, Afoxalaner inhibits the D. melanogaster RDL
GABA receptor (Shoop et al., 2014) and Sarolaner inhibits responses to
GABA of the cat ﬂea (Ctenocephalides felis) CfRDL GABA-gated chloride
channel (McTier et al., 2016).
Okaramine B shows insecticidal activity on larvae of the silkworm,
Bombyx mori (Hayashi et al., 1989). When applied to B. mori larval
neurons at 300 nM or higher concentrations, okaramine B resulted in
inward currents which reversed close to the chloride equilibrium po-
tential and were blocked by ﬁpronil (Furutani et al., 2014b). When
tested on a silkworm GABA receptor (BmRDL) and on BmGluCl ex-
pressed separately in X. laevis oocytes, okaramine B activated BmGluCl,
but not BmRDL (Furutani et al., 2014b). GluCl activation by 4 diﬀerent
members of the okaramine family correlated with their insecticidal
activity, with okaramine B being the most potent (Furutani et al.,
2017). Also, unlike ivermectin, okaramine B was inactive at 10 μM on
human α1β2γ2 GABA gated chloride channels and human α1β glycine-
gated chloride channels (Furutani et al., 2014b). Thus it oﬀers potential
promise as a new, highly-selective lead compound for the development
of new insect control chemicals targeting insect GluCls.
We have begun to explore the actions of okaramine B as a possible
acaricide lead and found that like picrotoxinin, ﬁpronil and ivermectin,
it is active on a tick GluCl (IscaGluCl1). As is the case with ivermectin,
its actions are much slower in onset than those of L-glutamate, sug-
gesting that it also activates IscaGluCl1 via an allosteric site rather than
acting via the orthosteric (agonist) site. Okaramine B was more readily
reversible than ivermectin (Fig. 5). Caution is required in interpreting
ﬁndings on a single subunit when other subunits remain to be explored
and the stoichiometry remains unknown for any invertebrate GluCl.
However, it will be of interest to explore further the actions of okar-
amine B on other recombinant IscaGluCls and also on native Ixodes
scapularis GluCls. Unlike ﬁpronil, ﬂuralaner and ivermectin, which in
insects act on both GluCls and GABA-gated chloride channels, okar-
amine B shows a stronger speciﬁcity for insect GluCls (Furutani et al.,
2014b), and it will be of interest to see if a similar selectivity holds in
the case of ticks. We cannot be sure that GluCl-selective compounds will
be of comparable eﬃcacy to compounds active on both GABARs and
GluCls but there is every likelihood that by not targeting a receptor also
found in mammals they may be safer. It will be important to develop
radioligand binding protocols applicable to native and expressed tick
GluCls to determine whether the binding sites of okaramine B and
ivermectin are distinct. If okaramine B acts at a site distinct from that of
ivermectin it may oﬀer a new, highly selective candidate lead for the
development of novel acaricides. It is interesting that en-
tomopathogenic fungi associated with the woodland habitat and even
collected from nymphal I. scapularis can be toxic to ticks. Intriguingly,
fungal species identiﬁed include Paewcolmyces sp., Lecanicillium sp. and
a species of Penicillium (Tuininga et al., 2009). Exploring further me-
tabolites of entomopathogenic fungi may well be fruitful therefore in
the search for new acaricides.
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